Skip to content
healthcare.dev

Zarontin

NDC 0071-0237, Ethosuximide, capsule, from Parke-Davis Div of Pfizer Inc.

Product NDC
0071-0237
Status
Listed
Labeler
Parke-Davis Div of Pfizer Inc
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA012380
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0071-0237 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ETHOSUXIMIDE250 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
0071-0237-2400071023724100 CAPSULE in 1 BOTTLE (0071-0237-24)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0e008f33-70a1-4bc6-b3a0-d45214418ab6
  • NADAC price for package 00071023724

    GET /v1/drugs/nadac/00071023724

Use it

Look up 0071-0237 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0071-0237 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0071-0237. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.